AdaptHealth Corp. (NASDAQ:AHCO) Shares Acquired by Invesco Ltd.

Invesco Ltd. boosted its stake in AdaptHealth Corp. (NASDAQ:AHCO - Free Report) by 12.2% during the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 1,433,172 shares of the company's stock after acquiring an additional 155,838 shares during the period. Invesco Ltd. owned 1.07% of AdaptHealth worth $13,644,000 at the end of the most recent reporting period.

A number of other hedge funds have also added to or reduced their stakes in the stock. Barclays PLC increased its holdings in shares of AdaptHealth by 361.3% during the third quarter. Barclays PLC now owns 181,240 shares of the company's stock valued at $2,034,000 after acquiring an additional 141,949 shares in the last quarter. Principal Financial Group Inc. increased its stake in AdaptHealth by 39.7% during the 3rd quarter. Principal Financial Group Inc. now owns 543,744 shares of the company's stock valued at $6,106,000 after purchasing an additional 154,434 shares in the last quarter. JPMorgan Chase & Co. raised its holdings in AdaptHealth by 73.2% in the third quarter. JPMorgan Chase & Co. now owns 191,833 shares of the company's stock worth $2,154,000 after buying an additional 81,097 shares during the last quarter. Reinhart Partners LLC. lifted its stake in shares of AdaptHealth by 1.1% in the fourth quarter. Reinhart Partners LLC. now owns 6,266,854 shares of the company's stock worth $59,660,000 after buying an additional 68,212 shares in the last quarter. Finally, Proficio Capital Partners LLC purchased a new stake in shares of AdaptHealth during the fourth quarter valued at approximately $181,000. 82.67% of the stock is owned by hedge funds and other institutional investors.

AdaptHealth Stock Up 3.9 %

Shares of AHCO traded up $0.30 during midday trading on Thursday, hitting $8.03. 2,411,079 shares of the company's stock traded hands, compared to its average volume of 1,238,810. AdaptHealth Corp. has a 1 year low of $7.11 and a 1 year high of $11.90. The firm's fifty day moving average is $9.61 and its 200-day moving average is $9.91. The company has a current ratio of 1.24, a quick ratio of 1.00 and a debt-to-equity ratio of 1.34. The stock has a market capitalization of $1.08 billion, a price-to-earnings ratio of -4.87, a price-to-earnings-growth ratio of 1.08 and a beta of 1.44.

Wall Street Analyst Weigh In

Several equities analysts recently issued reports on the company. Canaccord Genuity Group upped their price objective on AdaptHealth from $13.00 to $14.00 and gave the company a "buy" rating in a research report on Wednesday, February 26th. Truist Financial increased their price objective on AdaptHealth from $12.00 to $14.00 and gave the company a "buy" rating in a research report on Wednesday, February 26th. Robert W. Baird boosted their target price on AdaptHealth from $14.00 to $16.00 and gave the stock an "outperform" rating in a research report on Thursday, February 27th. Royal Bank of Canada raised their price target on shares of AdaptHealth from $11.00 to $14.00 and gave the company an "outperform" rating in a report on Wednesday, February 26th. Finally, UBS Group decreased their price objective on shares of AdaptHealth from $12.00 to $11.00 and set a "buy" rating for the company in a report on Thursday, February 13th. Five research analysts have rated the stock with a buy rating, According to MarketBeat, AdaptHealth currently has a consensus rating of "Buy" and a consensus price target of $13.80.

About AdaptHealth

AdaptHealth Corp., together with its subsidiaries, sells home medical equipment (HME), medical supplies, and home and related services in the United States. The company provides sleep therapy equipment, supplies, and related services, such as CPAP and bi-PAP services to individuals suffering from obstructive sleep apnea; medical devices and supplies, including continuous glucose monitors and insulin pumps for the treatment of diabetes; HME to patients discharged from acute care and other facilities; oxygen and related chronic therapy services in the home; and other HME devices and supplies on behalf of chronically ill patients with wound care, urological, incontinence, ostomy, and nutritional supply needs.